Loading the player ...
  • Share:
  • Embed
  • URL
  • Email Facebook Twitter ShareThis

Translational Medicine Symposium 2013: Dr. Emil Kakkis, 3 of 4

Emil Kakkis, M.D., Ph.D., president of Everylife Foundation and Ultragenyx Pharmaceuticals, presents "Improvement of the Development Process for Rare Disease Therapeutics" at the 2013 "Transforming Clinical and Translational Research" symposium hosted by the Harold and Muriel Block Institute for Clinical and Translational Research at Einstein and Montefiore (ICTR). (November 08, 2013)
  • Subscribe:
  • iTunes
  • YouTube